Guys, it’s my last theory and it’s been very encouraging since I started to read about kynurenine pathway.
SSRIs increases KAT activity and reduces KMO activity. This leads to excess ‘kynurenic acid’ and low ‘quinolinic acid’. The first one is a NMDA antagonist, dopamine negative regulator and a7 cholinergic receptor antagonist. The second one is mostly the opposite of it.
I won’t mention all of my problems in this post, in short, I have ‘terrible’ cognitive, emotional and motor dysfunction, also which is progressively worsening day by day.
I seriously need some help. I don’t know if this because a neuroinflammation or a enzyme downregulation, I don’t actually care. I just want to fix them all. I’m open for all suggestions.
New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio. - PubMed - NCBI
- I can’t get any antibitotic without a prescription
- Most of the supplements are unavailable and can’t be ordered from abroad
SSRIs increases KAT activity and reduces KMO activity. This leads to excess ‘kynurenic acid’ and low ‘quinolinic acid’. The first one is a NMDA antagonist, dopamine negative regulator and a7 cholinergic receptor antagonist. The second one is mostly the opposite of it.
I won’t mention all of my problems in this post, in short, I have ‘terrible’ cognitive, emotional and motor dysfunction, also which is progressively worsening day by day.
I seriously need some help. I don’t know if this because a neuroinflammation or a enzyme downregulation, I don’t actually care. I just want to fix them all. I’m open for all suggestions.
New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio. - PubMed - NCBI
- I can’t get any antibitotic without a prescription
- Most of the supplements are unavailable and can’t be ordered from abroad